AKT2 and diabetes mellitus: AKT, a downstream target of PI3K, appears to be essential for insulin signaling, as AKT-deficient mice have impaired insulin-induced glucose uptake in the liver and muscle [66,67], and humans with partial-loss-of function mutations in AKT2 have reduced glucose uptake in the liver and muscle and increased risk of diabetes [68].